Enhabit, Inc.
EHABNYSEHealthcare · Services-Home Health Care Services · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.06B | $1.03B | $1.05B | $1.07B | $1.11B | $1.08B |
| Operating income | $16.1M | −$115.1M | −$47.6M | −$11.4M | $142.9M | $102.7M |
| Net income | −$4.6M | −$156.2M | −$80.5M | −$40.4M | $111.1M | $75.0M |
| Total assets | $1.17B | $1.23B | $1.43B | $1.53B | $1.72B | — |
| Total liabilities | $603.0M | $672.1M | $731.9M | $751.5M | $236.7M | — |
| Equity | $534.0M | $523.5M | $669.7M | $741.7M | $1.47B | $1.39B |
| EPS (diluted) | $-0.09 | $-3.11 | $-1.61 | $-0.81 | $2.24 | $1.51 |
| Shares out. | 50.5M | 50.2M | 50.1M | 50.1M | 49.6M | 49.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 1.5%
- Net margin
- −0.4%
- Return on equity
- −0.9%
- Return on assets
- −0.4%
- Return on capital (ROCE)
- 1.5%
- Liabilities / assets
- 51.7%
- Debt / equity
- 1.13×
- Book value / share
- $10.58
- Revenue growth (YoY)
- 2.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 1.73grey zone
- Accruals / assets
- −6.5%clean
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 2 warning● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Reported a net loss
- Altman Z″ in the grey zone
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 3, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Balyasny Asset Management L.P.Passive (13G)May 15, 2026
- 8 Knots Management, LlcPassive (13G)Apr 10, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 139,847 | 1.0 | -88.4% |
| Apr 30, 2026 | 1.2M | 1.7 | -11.8% |
| Apr 15, 2026 | 1.4M | 1.3 | +1.3% |
| Mar 31, 2026 | 1.3M | 1.1 | -4.9% |
| Mar 13, 2026 | 1.4M | 1.0 | +14.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Regulation FD disclosureMay 15, 2026
- Shareholder vote · Other material eventMay 12, 2026
- Other material eventMay 5, 2026
- Other material eventApr 16, 2026
- Results of operations · Regulation FD disclosureMar 5, 2026
- Entered a material agreement · New financial obligationMar 4, 2026
- Director / officer changeFeb 27, 2026
- Entered a material agreement · Regulation FD disclosureFeb 23, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Corporate family
Spun off from Encompass Health CorporationEHC · Jul 1, 2022
From the spin-off filings we track. Follow a company to walk its own history.